Structure

Physi-Chem Properties

Molecular Weight:  636.21
Volume:  595.415
LogP:  1.119
LogD:  0.749
LogS:  -3.813
# Rotatable Bonds:  9
TPSA:  216.2
# H-Bond Aceptor:  15
# H-Bond Donor:  6
# Rings:  5
# Heavy Atoms:  15

MedChem Properties

QED Drug-Likeness Score:  0.175
Synthetic Accessibility Score:  4.679
Fsp3:  0.5
Lipinski Rule-of-5:  Rejected
Pfizer Rule:  Accepted
GSK Rule:  Rejected
BMS Rule:  0
Golden Triangle Rule:  Rejected
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -6.395
MDCK Permeability:  6.071214738767594e-05
Pgp-inhibitor:  0.006
Pgp-substrate:  0.997
Human Intestinal Absorption (HIA):  0.232
20% Bioavailability (F20%):  0.001
30% Bioavailability (F30%):  0.916

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.068
Plasma Protein Binding (PPB):  68.98479461669922%
Volume Distribution (VD):  0.478
Pgp-substrate:  15.586769104003906%

ADMET: Metabolism

CYP1A2-inhibitor:  0.026
CYP1A2-substrate:  0.948
CYP2C19-inhibitor:  0.051
CYP2C19-substrate:  0.363
CYP2C9-inhibitor:  0.012
CYP2C9-substrate:  0.238
CYP2D6-inhibitor:  0.068
CYP2D6-substrate:  0.275
CYP3A4-inhibitor:  0.044
CYP3A4-substrate:  0.024

ADMET: Excretion

Clearance (CL):  1.818
Half-life (T1/2):  0.301

ADMET: Toxicity

hERG Blockers:  0.655
Human Hepatotoxicity (H-HT):  0.117
Drug-inuced Liver Injury (DILI):  0.607
AMES Toxicity:  0.503
Rat Oral Acute Toxicity:  0.038
Maximum Recommended Daily Dose:  0.006
Skin Sensitization:  0.579
Carcinogencity:  0.069
Eye Corrosion:  0.003
Eye Irritation:  0.022
Respiratory Toxicity:  0.056

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC475155

Natural Product ID:  NPC475155
Common Name*:   4',5,6-Trimethoxyisoflavone-7-O-Alpha-L-Rhamnopyranosyl-(1->6)-Beta-D-Glucopyranoside
IUPAC Name:   5,6-dimethoxy-3-(4-methoxyphenyl)-7-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-[[(2R,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxymethyl]oxan-2-yl]oxychromen-4-one
Synonyms:  
Standard InCHIKey:  ACYJGXHSBCMABJ-RMRQORCVSA-N
Standard InCHI:  InChI=1S/C30H36O15/c1-12-20(31)23(34)25(36)29(43-12)42-11-18-22(33)24(35)26(37)30(45-18)44-17-9-16-19(28(40-4)27(17)39-3)21(32)15(10-41-16)13-5-7-14(38-2)8-6-13/h5-10,12,18,20,22-26,29-31,33-37H,11H2,1-4H3/t12-,18+,20-,22+,23+,24-,25+,26+,29+,30+/m0/s1
SMILES:  CC1C(C(C(C(O1)OCC2C(C(C(C(O2)OC3=C(C(=C4C(=C3)OC=C(C4=O)C5=CC=C(C=C5)OC)OC)OC)O)O)O)O)O)O
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL499535
PubChem CID:   25178391
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000261] Phenylpropanoids and polyketides
      • [CHEMONTID:0002506] Isoflavonoids
        • [CHEMONTID:0000507] Isoflavonoid O-glycosides

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO2687 Baphia bancoensis Species Fabaceae Eukaryota roots n.a. n.a. PMID[19007285]
NPO2687 Baphia bancoensis Species Fabaceae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT16 Organism Staphylococcus aureus Staphylococcus aureus MIC = 48400.0 nM PMID[506597]
NPT175 Organism Enterococcus faecalis Enterococcus faecalis MIC = 48400.0 nM PMID[506597]
NPT19 Organism Escherichia coli Escherichia coli MIC > 196300.0 nM PMID[506597]
NPT18 Organism Pseudomonas aeruginosa Pseudomonas aeruginosa MIC = 196300.0 nM PMID[506597]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC475155 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.9814 High Similarity NPC293004
0.9812 High Similarity NPC135345
0.9756 High Similarity NPC475261
0.9752 High Similarity NPC61791
0.9697 High Similarity NPC473895
0.9693 High Similarity NPC204693
0.9691 High Similarity NPC194483
0.9691 High Similarity NPC52353
0.9691 High Similarity NPC105511
0.9691 High Similarity NPC44558
0.9688 High Similarity NPC284277
0.9688 High Similarity NPC475366
0.9688 High Similarity NPC475497
0.9634 High Similarity NPC102028
0.9632 High Similarity NPC205076
0.9632 High Similarity NPC307518
0.9632 High Similarity NPC48773
0.9632 High Similarity NPC267254
0.963 High Similarity NPC472383
0.963 High Similarity NPC472381
0.9573 High Similarity NPC51774
0.9573 High Similarity NPC236191
0.9573 High Similarity NPC239549
0.9571 High Similarity NPC183357
0.9571 High Similarity NPC224462
0.9571 High Similarity NPC51326
0.9571 High Similarity NPC22195
0.9571 High Similarity NPC34287
0.9571 High Similarity NPC474434
0.9571 High Similarity NPC471416
0.9571 High Similarity NPC231194
0.9571 High Similarity NPC21190
0.9568 High Similarity NPC93099
0.9565 High Similarity NPC15358
0.9518 High Similarity NPC472387
0.9515 High Similarity NPC142996
0.9512 High Similarity NPC301683
0.9512 High Similarity NPC156977
0.9512 High Similarity NPC3583
0.9512 High Similarity NPC259152
0.9512 High Similarity NPC472386
0.9509 High Similarity NPC45638
0.9509 High Similarity NPC95855
0.9509 High Similarity NPC201292
0.9509 High Similarity NPC210042
0.9509 High Similarity NPC58053
0.9509 High Similarity NPC195257
0.9509 High Similarity NPC170675
0.9509 High Similarity NPC293629
0.9509 High Similarity NPC105025
0.9509 High Similarity NPC209296
0.9509 High Similarity NPC475942
0.9509 High Similarity NPC229687
0.9509 High Similarity NPC186807
0.9509 High Similarity NPC183036
0.9509 High Similarity NPC93337
0.9509 High Similarity NPC471457
0.9509 High Similarity NPC112755
0.9509 High Similarity NPC226294
0.9509 High Similarity NPC469931
0.95 High Similarity NPC182045
0.9464 High Similarity NPC473883
0.9461 High Similarity NPC470444
0.9461 High Similarity NPC473682
0.9461 High Similarity NPC126784
0.9461 High Similarity NPC470443
0.9461 High Similarity NPC110941
0.9461 High Similarity NPC241423
0.9461 High Similarity NPC473571
0.9458 High Similarity NPC169733
0.9455 High Similarity NPC208668
0.9451 High Similarity NPC79056
0.9451 High Similarity NPC105095
0.9451 High Similarity NPC44328
0.9451 High Similarity NPC177731
0.9448 High Similarity NPC229729
0.9448 High Similarity NPC58716
0.9448 High Similarity NPC45618
0.9448 High Similarity NPC45400
0.9448 High Similarity NPC146792
0.9437 High Similarity NPC110349
0.9408 High Similarity NPC148710
0.9401 High Similarity NPC476619
0.9401 High Similarity NPC476622
0.9401 High Similarity NPC476621
0.9401 High Similarity NPC476623
0.9401 High Similarity NPC476620
0.9401 High Similarity NPC476618
0.9394 High Similarity NPC172807
0.9394 High Similarity NPC256760
0.9394 High Similarity NPC254540
0.9394 High Similarity NPC211594
0.9394 High Similarity NPC476405
0.9394 High Similarity NPC117260
0.939 High Similarity NPC86008
0.939 High Similarity NPC43587
0.9387 High Similarity NPC115674
0.9387 High Similarity NPC99957
0.9387 High Similarity NPC181616
0.9387 High Similarity NPC210073
0.9387 High Similarity NPC236934
0.9387 High Similarity NPC5778
0.9387 High Similarity NPC70441
0.9383 High Similarity NPC127415
0.9383 High Similarity NPC309025
0.9383 High Similarity NPC88023
0.9383 High Similarity NPC243930
0.9349 High Similarity NPC473072
0.9349 High Similarity NPC470445
0.9349 High Similarity NPC470449
0.9349 High Similarity NPC470447
0.9349 High Similarity NPC470446
0.9341 High Similarity NPC472382
0.9341 High Similarity NPC8573
0.9341 High Similarity NPC472991
0.9341 High Similarity NPC470949
0.9341 High Similarity NPC257714
0.9341 High Similarity NPC472992
0.9341 High Similarity NPC65563
0.9341 High Similarity NPC472380
0.9341 High Similarity NPC472384
0.9337 High Similarity NPC45522
0.9337 High Similarity NPC24043
0.9337 High Similarity NPC101026
0.9337 High Similarity NPC21666
0.9337 High Similarity NPC169977
0.9337 High Similarity NPC42773
0.9333 High Similarity NPC78734
0.9333 High Similarity NPC245014
0.9333 High Similarity NPC282987
0.9333 High Similarity NPC150767
0.9333 High Similarity NPC84265
0.9325 High Similarity NPC311830
0.9325 High Similarity NPC165720
0.9325 High Similarity NPC22832
0.9321 High Similarity NPC148273
0.9294 High Similarity NPC470455
0.9294 High Similarity NPC470451
0.929 High Similarity NPC473073
0.929 High Similarity NPC473071
0.9286 High Similarity NPC168584
0.9281 High Similarity NPC294815
0.9281 High Similarity NPC264735
0.9281 High Similarity NPC19108
0.9281 High Similarity NPC477848
0.9281 High Similarity NPC476472
0.9281 High Similarity NPC198199
0.9281 High Similarity NPC16194
0.9281 High Similarity NPC472607
0.9281 High Similarity NPC220173
0.9281 High Similarity NPC473327
0.9277 High Similarity NPC261254
0.9277 High Similarity NPC235575
0.9277 High Similarity NPC180918
0.9273 High Similarity NPC105283
0.9268 High Similarity NPC8856
0.9264 High Similarity NPC94777
0.9264 High Similarity NPC270335
0.9264 High Similarity NPC88043
0.9264 High Similarity NPC222936
0.9264 High Similarity NPC29830
0.9264 High Similarity NPC284960
0.9264 High Similarity NPC168822
0.9264 High Similarity NPC191306
0.9264 High Similarity NPC19709
0.9259 High Similarity NPC303913
0.925 High Similarity NPC473657
0.925 High Similarity NPC295613
0.925 High Similarity NPC45165
0.9235 High Similarity NPC36138
0.9226 High Similarity NPC255799
0.9226 High Similarity NPC48984
0.9226 High Similarity NPC233994
0.9226 High Similarity NPC268533
0.9226 High Similarity NPC211532
0.9226 High Similarity NPC472385
0.9226 High Similarity NPC198324
0.9222 High Similarity NPC25724
0.9222 High Similarity NPC163165
0.9222 High Similarity NPC472993
0.9217 High Similarity NPC285197
0.9217 High Similarity NPC67105
0.9217 High Similarity NPC210808
0.9217 High Similarity NPC95866
0.9217 High Similarity NPC212748
0.9217 High Similarity NPC206123
0.9217 High Similarity NPC199079
0.9217 High Similarity NPC218488
0.9212 High Similarity NPC243877
0.9212 High Similarity NPC14662
0.9212 High Similarity NPC477502
0.9212 High Similarity NPC116745
0.9202 High Similarity NPC127782
0.9202 High Similarity NPC300537
0.9202 High Similarity NPC473043
0.9202 High Similarity NPC77660
0.9202 High Similarity NPC189142
0.9181 High Similarity NPC470416
0.9172 High Similarity NPC89052
0.9172 High Similarity NPC120952

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC475155 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.9509 High Similarity NPD7054 Approved
0.9451 High Similarity NPD7074 Phase 3
0.9451 High Similarity NPD7472 Approved
0.9281 High Similarity NPD7808 Phase 3
0.9222 High Similarity NPD7251 Discontinued
0.9212 High Similarity NPD3818 Discontinued
0.9167 High Similarity NPD4338 Clinical (unspecified phase)
0.9162 High Similarity NPD6797 Phase 2
0.9074 High Similarity NPD4381 Clinical (unspecified phase)
0.8929 High Similarity NPD7804 Clinical (unspecified phase)
0.8862 High Similarity NPD6167 Clinical (unspecified phase)
0.8862 High Similarity NPD6168 Clinical (unspecified phase)
0.8862 High Similarity NPD6166 Phase 2
0.8773 High Similarity NPD2801 Approved
0.8735 High Similarity NPD5494 Approved
0.8712 High Similarity NPD1934 Approved
0.8606 High Similarity NPD3817 Phase 2
0.8545 High Similarity NPD2393 Clinical (unspecified phase)
0.8476 Intermediate Similarity NPD4380 Phase 2
0.8443 Intermediate Similarity NPD4868 Clinical (unspecified phase)
0.8383 Intermediate Similarity NPD5402 Approved
0.8343 Intermediate Similarity NPD6559 Discontinued
0.8333 Intermediate Similarity NPD3882 Suspended
0.8323 Intermediate Similarity NPD7096 Clinical (unspecified phase)
0.8286 Intermediate Similarity NPD7993 Clinical (unspecified phase)
0.8284 Intermediate Similarity NPD7075 Discontinued
0.8276 Intermediate Similarity NPD5844 Phase 1
0.8232 Intermediate Similarity NPD7879 Clinical (unspecified phase)
0.8221 Intermediate Similarity NPD1511 Approved
0.8214 Intermediate Similarity NPD7819 Suspended
0.8155 Intermediate Similarity NPD6801 Discontinued
0.8133 Intermediate Similarity NPD1653 Approved
0.8125 Intermediate Similarity NPD2796 Approved
0.8121 Intermediate Similarity NPD1512 Approved
0.8072 Intermediate Similarity NPD6980 Clinical (unspecified phase)
0.8045 Intermediate Similarity NPD8312 Approved
0.8045 Intermediate Similarity NPD8313 Approved
0.8025 Intermediate Similarity NPD1549 Phase 2
0.8022 Intermediate Similarity NPD8397 Clinical (unspecified phase)
0.8011 Intermediate Similarity NPD7228 Approved
0.8011 Intermediate Similarity NPD3751 Discontinued
0.8 Intermediate Similarity NPD1465 Phase 2
0.8 Intermediate Similarity NPD6799 Approved
0.7989 Intermediate Similarity NPD3787 Discontinued
0.7988 Intermediate Similarity NPD7411 Suspended
0.7964 Intermediate Similarity NPD5403 Approved
0.7963 Intermediate Similarity NPD1550 Clinical (unspecified phase)
0.7963 Intermediate Similarity NPD1552 Clinical (unspecified phase)
0.7955 Intermediate Similarity NPD7473 Discontinued
0.7953 Intermediate Similarity NPD8443 Clinical (unspecified phase)
0.7952 Intermediate Similarity NPD5401 Approved
0.7952 Intermediate Similarity NPD4378 Clinical (unspecified phase)
0.7933 Intermediate Similarity NPD7685 Pre-registration
0.7931 Intermediate Similarity NPD1247 Approved
0.7931 Intermediate Similarity NPD7199 Phase 2
0.7931 Intermediate Similarity NPD6959 Discontinued
0.7886 Intermediate Similarity NPD6232 Discontinued
0.7844 Intermediate Similarity NPD7410 Clinical (unspecified phase)
0.784 Intermediate Similarity NPD1510 Phase 2
0.7833 Intermediate Similarity NPD7240 Approved
0.7831 Intermediate Similarity NPD6781 Approved
0.7831 Intermediate Similarity NPD6778 Approved
0.7831 Intermediate Similarity NPD6782 Approved
0.7831 Intermediate Similarity NPD6777 Approved
0.7831 Intermediate Similarity NPD6776 Approved
0.7831 Intermediate Similarity NPD6780 Approved
0.7831 Intermediate Similarity NPD6779 Approved
0.7824 Intermediate Similarity NPD6599 Discontinued
0.7801 Intermediate Similarity NPD7698 Approved
0.7801 Intermediate Similarity NPD7697 Approved
0.7801 Intermediate Similarity NPD7435 Discontinued
0.7801 Intermediate Similarity NPD7696 Phase 3
0.7791 Intermediate Similarity NPD8455 Phase 2
0.7784 Intermediate Similarity NPD8151 Discontinued
0.776 Intermediate Similarity NPD8055 Clinical (unspecified phase)
0.774 Intermediate Similarity NPD3926 Phase 2
0.774 Intermediate Similarity NPD7184 Clinical (unspecified phase)
0.7733 Intermediate Similarity NPD37 Approved
0.7732 Intermediate Similarity NPD7701 Phase 2
0.7714 Intermediate Similarity NPD919 Approved
0.7704 Intermediate Similarity NPD7782 Clinical (unspecified phase)
0.7704 Intermediate Similarity NPD7783 Phase 2
0.7701 Intermediate Similarity NPD4967 Phase 2
0.7701 Intermediate Similarity NPD4965 Approved
0.7701 Intermediate Similarity NPD4966 Approved
0.7697 Intermediate Similarity NPD7852 Clinical (unspecified phase)
0.768 Intermediate Similarity NPD7584 Approved
0.7668 Intermediate Similarity NPD7871 Phase 2
0.7668 Intermediate Similarity NPD7870 Phase 2
0.7656 Intermediate Similarity NPD6823 Phase 2
0.7654 Intermediate Similarity NPD1933 Approved
0.7636 Intermediate Similarity NPD7266 Discontinued
0.7632 Intermediate Similarity NPD7699 Phase 2
0.7632 Intermediate Similarity NPD7700 Phase 2
0.7614 Intermediate Similarity NPD6234 Discontinued
0.7605 Intermediate Similarity NPD1878 Clinical (unspecified phase)
0.7593 Intermediate Similarity NPD1240 Approved
0.7574 Intermediate Similarity NPD6143 Clinical (unspecified phase)
0.7566 Intermediate Similarity NPD6535 Approved
0.7566 Intermediate Similarity NPD6534 Approved
0.7563 Intermediate Similarity NPD7875 Clinical (unspecified phase)
0.7563 Intermediate Similarity NPD7874 Approved
0.7529 Intermediate Similarity NPD6844 Discontinued
0.7525 Intermediate Similarity NPD7801 Approved
0.75 Intermediate Similarity NPD3750 Approved
0.75 Intermediate Similarity NPD4628 Phase 3
0.75 Intermediate Similarity NPD1607 Approved
0.75 Intermediate Similarity NPD7768 Phase 2
0.7485 Intermediate Similarity NPD1613 Approved
0.7485 Intermediate Similarity NPD943 Approved
0.7485 Intermediate Similarity NPD1612 Clinical (unspecified phase)
0.747 Intermediate Similarity NPD2935 Discontinued
0.7469 Intermediate Similarity NPD6859 Clinical (unspecified phase)
0.7458 Intermediate Similarity NPD3749 Approved
0.7442 Intermediate Similarity NPD920 Approved
0.7439 Intermediate Similarity NPD447 Suspended
0.741 Intermediate Similarity NPD3748 Approved
0.7381 Intermediate Similarity NPD970 Clinical (unspecified phase)
0.7371 Intermediate Similarity NPD7501 Clinical (unspecified phase)
0.7356 Intermediate Similarity NPD7458 Discontinued
0.7353 Intermediate Similarity NPD6190 Approved
0.734 Intermediate Similarity NPD8150 Discontinued
0.734 Intermediate Similarity NPD8434 Phase 2
0.7337 Intermediate Similarity NPD6674 Discontinued
0.7337 Intermediate Similarity NPD7421 Clinical (unspecified phase)
0.7333 Intermediate Similarity NPD230 Phase 1
0.733 Intermediate Similarity NPD6212 Phase 3
0.733 Intermediate Similarity NPD6213 Phase 3
0.733 Intermediate Similarity NPD6214 Clinical (unspecified phase)
0.7326 Intermediate Similarity NPD642 Clinical (unspecified phase)
0.7323 Intermediate Similarity NPD7583 Approved
0.731 Intermediate Similarity NPD8320 Phase 1
0.731 Intermediate Similarity NPD8319 Approved
0.7306 Intermediate Similarity NPD8090 Clinical (unspecified phase)
0.7301 Intermediate Similarity NPD3027 Phase 3
0.7286 Intermediate Similarity NPD7585 Approved
0.7262 Intermediate Similarity NPD1551 Phase 2
0.7257 Intermediate Similarity NPD3226 Approved
0.7256 Intermediate Similarity NPD2313 Discontinued
0.7247 Intermediate Similarity NPD5353 Approved
0.7239 Intermediate Similarity NPD1529 Clinical (unspecified phase)
0.7239 Intermediate Similarity NPD6832 Phase 2
0.7235 Intermediate Similarity NPD1243 Approved
0.7231 Intermediate Similarity NPD7237 Clinical (unspecified phase)
0.7225 Intermediate Similarity NPD2533 Approved
0.7225 Intermediate Similarity NPD2534 Approved
0.7225 Intermediate Similarity NPD2532 Approved
0.7222 Intermediate Similarity NPD2798 Approved
0.7219 Intermediate Similarity NPD2346 Discontinued
0.7209 Intermediate Similarity NPD643 Clinical (unspecified phase)
0.7204 Intermediate Similarity NPD5953 Discontinued
0.7202 Intermediate Similarity NPD2799 Discontinued
0.7198 Intermediate Similarity NPD8155 Clinical (unspecified phase)
0.7189 Intermediate Similarity NPD7286 Phase 2
0.7178 Intermediate Similarity NPD1530 Clinical (unspecified phase)
0.7172 Intermediate Similarity NPD7680 Approved
0.7158 Intermediate Similarity NPD5242 Approved
0.7143 Intermediate Similarity NPD8127 Discontinued
0.7135 Intermediate Similarity NPD2800 Approved
0.7128 Intermediate Similarity NPD7549 Discontinued
0.7126 Intermediate Similarity NPD7004 Clinical (unspecified phase)
0.7125 Intermediate Similarity NPD1547 Clinical (unspecified phase)
0.712 Intermediate Similarity NPD6841 Approved
0.712 Intermediate Similarity NPD6843 Phase 3
0.712 Intermediate Similarity NPD7784 Clinical (unspecified phase)
0.712 Intermediate Similarity NPD6842 Approved
0.7101 Intermediate Similarity NPD7033 Discontinued
0.7079 Intermediate Similarity NPD6386 Approved
0.7079 Intermediate Similarity NPD6385 Approved
0.7059 Intermediate Similarity NPD6100 Approved
0.7059 Intermediate Similarity NPD6099 Approved
0.7041 Intermediate Similarity NPD7097 Phase 1
0.7037 Intermediate Similarity NPD4419 Clinical (unspecified phase)
0.7035 Intermediate Similarity NPD5005 Approved
0.7035 Intermediate Similarity NPD1652 Phase 2
0.7035 Intermediate Similarity NPD5006 Approved
0.7028 Intermediate Similarity NPD8058 Clinical (unspecified phase)
0.7028 Intermediate Similarity NPD8059 Phase 3
0.7026 Intermediate Similarity NPD4360 Phase 2
0.7026 Intermediate Similarity NPD4363 Phase 3
0.7024 Intermediate Similarity NPD1899 Clinical (unspecified phase)
0.7019 Intermediate Similarity NPD1091 Approved
0.7018 Intermediate Similarity NPD2344 Approved
0.7015 Intermediate Similarity NPD7211 Clinical (unspecified phase)
0.7006 Intermediate Similarity NPD6233 Phase 2
0.7 Intermediate Similarity NPD651 Clinical (unspecified phase)
0.6994 Remote Similarity NPD6398 Clinical (unspecified phase)
0.6983 Remote Similarity NPD7615 Clinical (unspecified phase)
0.6982 Remote Similarity NPD6651 Approved
0.6971 Remote Similarity NPD7390 Discontinued
0.697 Remote Similarity NPD9494 Approved
0.6967 Remote Similarity NPD5619 Clinical (unspecified phase)
0.6966 Remote Similarity NPD5808 Clinical (unspecified phase)
0.6946 Remote Similarity NPD6798 Discontinued
0.6928 Remote Similarity NPD4908 Phase 1
0.6923 Remote Similarity NPD6355 Discontinued
0.6923 Remote Similarity NPD5123 Clinical (unspecified phase)
0.6923 Remote Similarity NPD5124 Phase 1
0.6919 Remote Similarity NPD7229 Phase 3
0.6919 Remote Similarity NPD4420 Approved

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data